Written by Klarity Editorial Team
Published: Jul 12, 2026

Last updated: July 12, 2026
If you have Cigna health insurance and live in New Mexico, you may be wondering whether your plan helps pay for ADHD evaluation, therapy, and medication. The short answer is that Cigna commercial plans typically include mental health benefits that may cover ADHD treatment, but coverage details, prior authorization requirements, and formulary tiers vary significantly by plan. This guide explains what Cigna members in New Mexico generally encounter when seeking ADHD care, including key 2026 pharmacy policy changes from Express Scripts (Cigna’s pharmacy benefits manager).
See if your Cigna plan may cover ADHD treatment at Klarity Health. Klarity’s licensed providers serve New Mexico patients via telehealth and accept many Cigna plans. Check ADHD Treatment Options
Cigna commercial plans sold in New Mexico are generally required to include mental health benefits under the Affordable Care Act’s essential health benefits framework and New Mexico’s mental health parity law (NMSA 1978 § 59A-23E-19 et seq.). This means Cigna typically may not impose more restrictive treatment limitations on mental health conditions like ADHD than it does on comparable medical or surgical conditions.
In practice, covered ADHD services under Cigna plans often include:
Coverage amounts — including deductibles, copays, and out-of-pocket maximums — vary by plan type (HMO, PPO, HSA-eligible, etc.). Always verify your specific benefits before scheduling care.
Cigna administers prescription drug benefits through Express Scripts (ESI). ESI maintains its own national drug formulary, which determines which medications are covered and at what cost-sharing tier.
For ADHD medications, the general ESI formulary structure in 2026 is:
| Medication | Type | Typical Tier | PA Required? |
|---|---|---|---|
| Amphetamine salts (Adderall generic) | Stimulant — Schedule II | Tier 1–2 (generic preferred) | Yes — see IP0477 |
| Methylphenidate (Ritalin generic) | Stimulant — Schedule II | Tier 1–2 (generic preferred) | Yes — see IP0477 |
| Lisdexamfetamine (Vyvanse generic) | Stimulant — Schedule II | Tier 2–3 (verify with plan) | Yes — see IP0477 |
| Adderall XR, Concerta (brand) | Stimulant — Schedule II | Tier 3–4 (step therapy) | Yes — step therapy + PA |
| Atomoxetine (Strattera generic) | Non-stimulant | Tier 1–2 | Often not required |
| Viloxazine (Qelbree) | Non-stimulant | Tier 2–3 | PA often required |
| Guanfacine ER (Intuniv generic) | Non-stimulant | Tier 1–2 | Varies by plan |
Tiers and PA requirements reflect general ESI formulary patterns for 2026. Your specific plan’s formulary may differ — always verify coverage at your plan’s member portal or by calling ESI at 1-800-835-3784.
Effective May 15, 2026, Cigna implemented Prior Authorization policy IP0477, which requires prior authorization for all stimulant medications prescribed for ADHD — including generics that may not have required PA in prior years.
Key points about IP0477:
Klarity Health’s licensed providers are experienced with PA requirements and can submit supporting clinical documentation on your behalf when prescribing ADHD medication.
Ready to get started? Klarity’s New Mexico-licensed providers treat ADHD via telehealth and can assist with PA submissions for covered Cigna members. Explore ADHD Treatment at Klarity
Because stimulant ADHD medications (amphetamine salts, methylphenidate, lisdexamfetamine) are classified as Schedule II controlled substances under the federal Controlled Substances Act, they are subject to Electronic Prescriptions for Controlled Substances (EPCS) requirements under DEA regulations (21 CFR Part 1311).
EPCS rules require prescribers to use DEA-compliant, identity-verified electronic prescribing software for all Schedule II prescriptions. New Mexico has additionally adopted state-level EPCS requirements. Klarity Health’s telehealth platform is fully EPCS-compliant, so your provider can prescribe stimulant medications electronically and securely when clinically appropriate.
Note: Non-stimulant ADHD medications (atomoxetine, guanfacine, viloxazine) are not Schedule II and do not require EPCS — they may be prescribed via standard electronic prescribing.
New Mexico’s mental health parity statute (NMSA 1978 § 59A-23E-19 et seq.) requires state-regulated health insurers to provide mental health and substance use disorder benefits at parity with medical and surgical benefits. This means Cigna commercial plans issued in New Mexico generally may not:
Important limitation: Self-funded employer plans (where your employer pays claims directly rather than purchasing fully insured coverage) are governed by the federal Employee Retirement Income Security Act (ERISA) and are generally exempt from New Mexico state parity requirements. Federal Mental Health Parity and Addiction Equity Act (MHPAEA) protections still apply to self-funded plans. If you are unsure whether your plan is fully insured or self-funded, check your Summary Plan Description or call Cigna member services.
Before scheduling ADHD care, take these steps to understand your specific benefits:
Cigna commercial plans in New Mexico typically may cover outpatient mental health evaluations, which can include ADHD assessment by a licensed clinician. Coverage is subject to your plan’s deductible and cost-sharing. Check your benefits for “outpatient mental health” and confirm your provider is in-network.
Many Cigna plans cover telehealth mental health services at parity with in-person visits, particularly post-pandemic. Klarity Health’s licensed New Mexico providers offer telehealth ADHD evaluation and medication management that may be covered by your Cigna plan.
If your Cigna plan covers ADHD medications and your telehealth provider submits the required prior authorization under policy IP0477, generic amphetamine salts (Adderall generic) may be covered at Tier 1–2 cost-sharing. Telehealth prescriptions for Schedule II stimulants are valid when issued by a DEA-registered provider using EPCS-compliant software.
You have the right to appeal a PA denial. First, request an internal appeal through Cigna. If that is denied, you may request an external independent review. New Mexico law requires external review rights for most covered individuals. Contact NM OSI at 1-855-427-5674 if you need assistance navigating an appeal.
A generic version of lisdexamfetamine became available, and ESI typically places it at Tier 2–3. Brand Vyvanse would typically require step therapy demonstrating a trial of a generic stimulant first, plus PA. Verify current tier placement with ESI at 1-800-835-3784.
Klarity Health connects New Mexico residents with 2,000+ licensed providers for telehealth ADHD evaluation and treatment. Our providers are experienced with Cigna’s prior authorization requirements and can support your coverage journey from initial assessment through ongoing medication management.
Coverage disclaimer: Insurance coverage varies by plan, employer, and individual benefit design. The information in this guide reflects general Cigna and ESI policy patterns for 2026 and does not constitute a guarantee of coverage. Always verify your specific benefits with Cigna (1-800-244-6224) and ESI (1-800-835-3784) before scheduling care.
Check Your ADHD Treatment Options
Find the right provider for your needs — select your state to find expert care near you.